Fund HoldingsAquilo Capital Management, LLC

Total Portfolio Value
$37.08M
Total Bought
$19.37M
Total Sold
$21.95M
Net Transaction
-$2.58M
Filing Period:
Securities
SharesValue ($K)
Q4 2024
Q1 2025
Change
Q4 2024
Q1 2025
Weight (%)
Change
AMGEN INC(AMGN)(Call)25,00060,000+35,0006,51618,693+12,177
PRECISION BIOSCIENCES INC536,376726,149+189,7732,0443,4649.34%+1,420
ZYMEWORKS INC(ZYME)084,482+84,48201,0062.71%+1,006
PROTAGONIST THERAPEUTICS INC76,59281,692+5,1002,9563,95110.65%+994
SUTRO BIOPHARMA INC4980-49810-1
REPARE THERAPEUTICS INC1,293,7151,293,71501,6951,2753.44%-419
ADICET BIO INC2,531,1942,456,194-75,0002,4351,8545.00%-581
REGENXBIO INC346,302271,302-75,0002,6771,9405.23%-737
IMMATICS N.V(IMTX)373,902304,902-69,0002,6581,3753.71%-1,283
ARROWHEAD PHARMACEUTICALS IN(ARWR)(Call)75,0000-75,0001,4100-1,410
BICYCLE THERAPEUTICS PLC221,911171,695-50,2163,1071,4583.93%-1,649
SILENCE THERAPEUTICS PLC367,2140-367,2142,5260-2,526
KYMERA THERAPEUTICS INC(KYMR)183,521138,521-45,0007,3833,79110.22%-3,592
ARVINAS INC328,766360,766+32,0006,3022,5336.83%-3,770
BLUEPRINT MEDICINES CORP129,60083,926-45,67411,3047,42820.03%-3,875
ARROWHEAD PHARMACEUTICALS IN(ARWR)707,589550,130-157,45913,3037,00918.90%-6,294
Page 1 of 1